Dyserythropoiesis and myelodysplasia in thiamine-responsive megaloblastic anemia syndrome.

Mojgan Faraji-Goodarzi Fariba Tarhani Nadereh Taee

Published in: Clinical case reports (2020)

The case of thiamine-responsive megaloblastic anemia (TRMA) presented here speculates the need early diagnosis, continuous monitoring, follow-up, and regulated treatment plan for the patients. Complications and systemic manifestations are likely to enhance in otherwise circumstances.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
cancer therapy
peritoneal dialysis
iron deficiency
transcription factor
drug delivery
drug induced